# Cessation of Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myelogenous Leukaemia

> **NCT03131986** · — · UNKNOWN · sponsor: **The University of Hong Kong** · enrollment: 30 (estimated)

## Conditions studied

- Leukemia, Myelogenous, Chronic Phase

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03131986
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-18
- **Primary completion:** 2019-03-30
- **Final completion:** 2019-03-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03131986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03131986, "Cessation of Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myelogenous Leukaemia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03131986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*